A new study in mice has shown blood cancer treatment with protein interleukin-7 revs up T-cell immunotherapy.
List view / Grid view
Washington University School of Medicine in St. Louis
Scientists discover a long noncoding RNA, termed NXTAR, and a small molecule drug that could be used to treat prostate cancer.
US researchers have identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that could be used against these targets.
Researchers have shown that natural killer cell immunotherapy effectively treated mice harbouring human melanoma tumours.
In mice and hamsters, therapies made from two antibodies were found to be mostly effective against a range of SARS-CoV-2 variants.
Scientists have developed an implant that releases insulin-secreting cells which has shown success at treating diabetes in mice.
A monoclonal antibody (mAb) cocktail, that targets sites on the Spike protein other than the E484K residue, can neutralise SARS-CoV-2.
A new study has shown that the mutated FBXO31 and RHOB genes can each alone cause cerebral palsy, offering potential drug targets.
A potential COVID-19 vaccine, made from a modified vesicular stomatitis virus with the SARS-CoV-2 Spike protein, was shown to protect mice against the virus.
Induced pluripotent stem cells made to produce insulin and CRISPR, used to correct a genetic defect, cured Wolfram syndrome in mice.
Researchers have shown that natural killer (NK) cells work best as an immunotherapy when in an early stage of development, so could be manufactured from pluripotent stem cells.
Researchers have found that using IL-15 to boost natural killer cell numbers in mice helps to combat eczema and could be a therapeutic strategy for patients.
Researchers have found a set of genes which helps cells survive during sepsis in mice and could inform potential treatments for the condition.
Researchers have found that certain immune cells aid in fighting tuberculosis bacteria, providing a new drug target.